Miguel Bastos

ORCID: 0000-0003-3569-0139
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bacteriophages and microbial interactions
  • Glycosylation and Glycoproteins Research
  • Cancer-related Molecular Pathways
  • Chronic Lymphocytic Leukemia Research
  • Antimicrobial Resistance in Staphylococcus
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • RNA and protein synthesis mechanisms
  • Chromosomal and Genetic Variations
  • Genomics and Phylogenetic Studies
  • CRISPR and Genetic Engineering
  • Bacterial Genetics and Biotechnology
  • Immunotherapy and Immune Responses
  • Bacterial Identification and Susceptibility Testing

Centro de Investigación del Cáncer
2022-2023

Universidad de Salamanca
2023

Centro de Investigación Biomédica en Red de Cáncer
2022-2023

Instituto de Investigación Biomédica de Salamanca
2022-2023

Universidade Federal do Rio de Janeiro
1999

University of Michigan
1997

Paenibacillus polymyxa strain SCE2 was shown to inhibit the growth of different potential human pathogenic bacterial strains and fungi in vitro. To determine genetic characterization this antimicrobial substance, transformed with plasmid pTV32(Ts), a delivery vector for Tn917-lac. After transposition, four mutants were have lost their capability Micrococcus sp. Staphylococcus aureus RN450, but they continued Corynebacterium fimi NCTC7547 Escherichia coli HB101. Hybridization experiments...

10.1046/j.1365-2672.1999.00563.x article EN Letters in Applied Microbiology 1999-06-01

The enterococcal, conjugative, cytolysin plasmid pAD1 confers a mating response to the peptide sex pheromone cAD1 secreted by plasmid-free strains of Enterococcus faecalis. Cells carrying pAM714, pAD1::Tn917 derivative with wild-type conjugation properties, were mutagenized ethyl methanesulfonate obtain variants that induced (in absence pheromone) transfer DNA upon shifting from 32 42 degrees C. Of 31 such mutants generated, results analyses 7 are presented in detail. All seven...

10.1128/jb.179.10.3250-3259.1997 article EN Journal of Bacteriology 1997-05-01

Chronic lymphocytic leukemia (CLL) is a hematologic malignancy characterized by progressive accumulation of rare population CD5+ B-lymphocytes in peripheral blood, bone marrow, and lymphoid tissues. CLL exhibits remarkable clinical heterogeneity, with some patients presenting indolent disease others progressing rapidly to aggressive CLL. The significant heterogeneity underscores the importance identifying novel prognostic markers. Recently, RAS-related gene RRAS2 has emerged as both driver...

10.3390/cells12232687 article EN cc-by Cells 2023-11-22

A single nucleotide polymorphism in intron 1 determines the new HLA-A*23:01:01:27 allele.

10.1111/tan.14579 article EN HLA 2022-02-14

Chronic lymphocytic leukemia (CLL) is a hematologic malignancy characterized by progressive accumulation of rare population CD5+ B lymphocytes in peripheral blood, bone marrow and lymphoid tissues. CLL exhibits remarkable clinical heterogeneity, with some patients presenting indolent disease others progressing rapidly to aggressive CLL. The significant heterogeneity underscores the importance identifying novel prognostic markers. Recently, RAS-related gene RRAS2 has emerged as both driver...

10.20944/preprints202310.1792.v1 preprint EN 2023-10-27
Coming Soon ...